Global Cancer Immuno Personalized Medicine Market Growth (Status and Outlook) 2024-2030
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Cancer Immuno Personalized Medicine Market Size 2019-2030 2.1.2 Cancer Immuno Personalized Medicine Market Size CAGR by Region (2019 VS 2023 VS 2030) 2.1.3 World Current & Future Analysis for Cancer Immuno Personalized Medicine by Country/Region, 2019, 2023 & 2030 2.2 Cancer Immuno Personalized Medicine Segment by Type 2.2.1 Immune Checkpoint Inhibitors 2.2.2 Cytokine-Based Immunotherapy 2.2.3 CAR-T Cell Therapy 2.2.4 Other 2.3 Cancer Immuno Personalized Medicine Market Size by Type 2.3.1 Cancer Immuno Personalized Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Cancer Immuno Personalized Medicine Market Size Market Share by Type (2019-2024) 2.4 Cancer Immuno Personalized Medicine Segment by Application 2.4.1 Lung Cancer 2.4.2 Breast Cancer 2.4.3 Prostate Cancer 2.4.4 Blood-related Cancer 2.4.5 Other 2.5 Cancer Immuno Personalized Medicine Market Size by Application 2.5.1 Cancer Immuno Personalized Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Cancer Immuno Personalized Medicine Market Size Market Share by Application (2019-2024) 3 Cancer Immuno Personalized Medicine Market Size by Player 3.1 Cancer Immuno Personalized Medicine Market Size Market Share by Player 3.1.1 Global Cancer Immuno Personalized Medicine Revenue by Player (2019-2024) 3.1.2 Global Cancer Immuno Personalized Medicine Revenue Market Share by Player (2019-2024) 3.2 Global Cancer Immuno Personalized Medicine Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Cancer Immuno Personalized Medicine by Region 4.1 Cancer Immuno Personalized Medicine Market Size by Region (2019-2024) 4.2 Global Cancer Immuno Personalized Medicine Annual Revenue by Country/Region (2019-2024) 4.3 Americas Cancer Immuno Personalized Medicine Market Size Growth (2019-2024) 4.4 APAC Cancer Immuno Personalized Medicine Market Size Growth (2019-2024) 4.5 Europe Cancer Immuno Personalized Medicine Market Size Growth (2019-2024) 4.6 Middle East & Africa Cancer Immuno Personalized Medicine Market Size Growth (2019-2024) 5 Americas 5.1 Americas Cancer Immuno Personalized Medicine Market Size by Country (2019-2024) 5.2 Americas Cancer Immuno Personalized Medicine Market Size by Type (2019-2024) 5.3 Americas Cancer Immuno Personalized Medicine Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Cancer Immuno Personalized Medicine Market Size by Region (2019-2024) 6.2 APAC Cancer Immuno Personalized Medicine Market Size by Type (2019-2024) 6.3 APAC Cancer Immuno Personalized Medicine Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Cancer Immuno Personalized Medicine Market Size by Country (2019-2024) 7.2 Europe Cancer Immuno Personalized Medicine Market Size by Type (2019-2024) 7.3 Europe Cancer Immuno Personalized Medicine Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Cancer Immuno Personalized Medicine by Region (2019-2024) 8.2 Middle East & Africa Cancer Immuno Personalized Medicine Market Size by Type (2019-2024) 8.3 Middle East & Africa Cancer Immuno Personalized Medicine Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Cancer Immuno Personalized Medicine Market Forecast 10.1 Global Cancer Immuno Personalized Medicine Forecast by Region (2025-2030) 10.1.1 Global Cancer Immuno Personalized Medicine Forecast by Region (2025-2030) 10.1.2 Americas Cancer Immuno Personalized Medicine Forecast 10.1.3 APAC Cancer Immuno Personalized Medicine Forecast 10.1.4 Europe Cancer Immuno Personalized Medicine Forecast 10.1.5 Middle East & Africa Cancer Immuno Personalized Medicine Forecast 10.2 Americas Cancer Immuno Personalized Medicine Forecast by Country (2025-2030) 10.2.1 United States Market Cancer Immuno Personalized Medicine Forecast 10.2.2 Canada Market Cancer Immuno Personalized Medicine Forecast 10.2.3 Mexico Market Cancer Immuno Personalized Medicine Forecast 10.2.4 Brazil Market Cancer Immuno Personalized Medicine Forecast 10.3 APAC Cancer Immuno Personalized Medicine Forecast by Region (2025-2030) 10.3.1 China Cancer Immuno Personalized Medicine Market Forecast 10.3.2 Japan Market Cancer Immuno Personalized Medicine Forecast 10.3.3 Korea Market Cancer Immuno Personalized Medicine Forecast 10.3.4 Southeast Asia Market Cancer Immuno Personalized Medicine Forecast 10.3.5 India Market Cancer Immuno Personalized Medicine Forecast 10.3.6 Australia Market Cancer Immuno Personalized Medicine Forecast 10.4 Europe Cancer Immuno Personalized Medicine Forecast by Country (2025-2030) 10.4.1 Germany Market Cancer Immuno Personalized Medicine Forecast 10.4.2 France Market Cancer Immuno Personalized Medicine Forecast 10.4.3 UK Market Cancer Immuno Personalized Medicine Forecast 10.4.4 Italy Market Cancer Immuno Personalized Medicine Forecast 10.4.5 Russia Market Cancer Immuno Personalized Medicine Forecast 10.5 Middle East & Africa Cancer Immuno Personalized Medicine Forecast by Region (2025-2030) 10.5.1 Egypt Market Cancer Immuno Personalized Medicine Forecast 10.5.2 South Africa Market Cancer Immuno Personalized Medicine Forecast 10.5.3 Israel Market Cancer Immuno Personalized Medicine Forecast 10.5.4 Turkey Market Cancer Immuno Personalized Medicine Forecast 10.6 Global Cancer Immuno Personalized Medicine Forecast by Type (2025-2030) 10.7 Global Cancer Immuno Personalized Medicine Forecast by Application (2025-2030) 10.7.1 GCC Countries Market Cancer Immuno Personalized Medicine Forecast 11 Key Players Analysis 11.1 AbbVie 11.1.1 AbbVie Company Information 11.1.2 AbbVie Cancer Immuno Personalized Medicine Product Offered 11.1.3 AbbVie Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 AbbVie Main Business Overview 11.1.5 AbbVie Latest Developments 11.2 Johnson & Johnson 11.2.1 Johnson & Johnson Company Information 11.2.2 Johnson & Johnson Cancer Immuno Personalized Medicine Product Offered 11.2.3 Johnson & Johnson Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Johnson & Johnson Main Business Overview 11.2.5 Johnson & Johnson Latest Developments 11.3 Novartis 11.3.1 Novartis Company Information 11.3.2 Novartis Cancer Immuno Personalized Medicine Product Offered 11.3.3 Novartis Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Novartis Main Business Overview 11.3.5 Novartis Latest Developments 11.4 Gilead Sciences 11.4.1 Gilead Sciences Company Information 11.4.2 Gilead Sciences Cancer Immuno Personalized Medicine Product Offered 11.4.3 Gilead Sciences Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Gilead Sciences Main Business Overview 11.4.5 Gilead Sciences Latest Developments 11.5 Roche 11.5.1 Roche Company Information 11.5.2 Roche Cancer Immuno Personalized Medicine Product Offered 11.5.3 Roche Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Roche Main Business Overview 11.5.5 Roche Latest Developments 11.6 Bristol-Myers Squibb 11.6.1 Bristol-Myers Squibb Company Information 11.6.2 Bristol-Myers Squibb Cancer Immuno Personalized Medicine Product Offered 11.6.3 Bristol-Myers Squibb Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Bristol-Myers Squibb Main Business Overview 11.6.5 Bristol-Myers Squibb Latest Developments 11.7 Amgen 11.7.1 Amgen Company Information 11.7.2 Amgen Cancer Immuno Personalized Medicine Product Offered 11.7.3 Amgen Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Amgen Main Business Overview 11.7.5 Amgen Latest Developments 11.8 AstraZeneca 11.8.1 AstraZeneca Company Information 11.8.2 AstraZeneca Cancer Immuno Personalized Medicine Product Offered 11.8.3 AstraZeneca Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 AstraZeneca Main Business Overview 11.8.5 AstraZeneca Latest Developments 11.9 Merck & Co 11.9.1 Merck & Co Company Information 11.9.2 Merck & Co Cancer Immuno Personalized Medicine Product Offered 11.9.3 Merck & Co Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Merck & Co Main Business Overview 11.9.5 Merck & Co Latest Developments 11.10 Takeda 11.10.1 Takeda Company Information 11.10.2 Takeda Cancer Immuno Personalized Medicine Product Offered 11.10.3 Takeda Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Takeda Main Business Overview 11.10.5 Takeda Latest Developments 11.11 Merck KGaA 11.11.1 Merck KGaA Company Information 11.11.2 Merck KGaA Cancer Immuno Personalized Medicine Product Offered 11.11.3 Merck KGaA Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 Merck KGaA Main Business Overview 11.11.5 Merck KGaA Latest Developments 11.12 Seagen 11.12.1 Seagen Company Information 11.12.2 Seagen Cancer Immuno Personalized Medicine Product Offered 11.12.3 Seagen Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 Seagen Main Business Overview 11.12.5 Seagen Latest Developments 11.13 Eli Lilly 11.13.1 Eli Lilly Company Information 11.13.2 Eli Lilly Cancer Immuno Personalized Medicine Product Offered 11.13.3 Eli Lilly Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.13.4 Eli Lilly Main Business Overview 11.13.5 Eli Lilly Latest Developments 11.14 Ono Pharmaceutical 11.14.1 Ono Pharmaceutical Company Information 11.14.2 Ono Pharmaceutical Cancer Immuno Personalized Medicine Product Offered 11.14.3 Ono Pharmaceutical Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.14.4 Ono Pharmaceutical Main Business Overview 11.14.5 Ono Pharmaceutical Latest Developments 11.15 Pfizer 11.15.1 Pfizer Company Information 11.15.2 Pfizer Cancer Immuno Personalized Medicine Product Offered 11.15.3 Pfizer Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.15.4 Pfizer Main Business Overview 11.15.5 Pfizer Latest Developments 11.16 GSK 11.16.1 GSK Company Information 11.16.2 GSK Cancer Immuno Personalized Medicine Product Offered 11.16.3 GSK Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.16.4 GSK Main Business Overview 11.16.5 GSK Latest Developments 11.17 Exelixis 11.17.1 Exelixis Company Information 11.17.2 Exelixis Cancer Immuno Personalized Medicine Product Offered 11.17.3 Exelixis Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.17.4 Exelixis Main Business Overview 11.17.5 Exelixis Latest Developments 11.18 Regeneron 11.18.1 Regeneron Company Information 11.18.2 Regeneron Cancer Immuno Personalized Medicine Product Offered 11.18.3 Regeneron Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.18.4 Regeneron Main Business Overview 11.18.5 Regeneron Latest Developments 11.19 Innovent 11.19.1 Innovent Company Information 11.19.2 Innovent Cancer Immuno Personalized Medicine Product Offered 11.19.3 Innovent Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.19.4 Innovent Main Business Overview 11.19.5 Innovent Latest Developments 11.20 Hengrui Medicine 11.20.1 Hengrui Medicine Company Information 11.20.2 Hengrui Medicine Cancer Immuno Personalized Medicine Product Offered 11.20.3 Hengrui Medicine Cancer Immuno Personalized Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.20.4 Hengrui Medicine Main Business Overview 11.20.5 Hengrui Medicine Latest Developments 12 Research Findings and Conclusion
List of Tables Table 1. Cancer Immuno Personalized Medicine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions) Table 2. Cancer Immuno Personalized Medicine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of Immune Checkpoint Inhibitors Table 4. Major Players of Cytokine-Based Immunotherapy Table 5. Major Players of CAR-T Cell Therapy Table 6. Major Players of Other Table 7. Cancer Immuno Personalized Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions) Table 8. Global Cancer Immuno Personalized Medicine Market Size by Type (2019-2024) & ($ millions) Table 9. Global Cancer Immuno Personalized Medicine Market Size Market Share by Type (2019-2024) Table 10. Cancer Immuno Personalized Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions) Table 11. Global Cancer Immuno Personalized Medicine Market Size by Application (2019-2024) & ($ millions) Table 12. Global Cancer Immuno Personalized Medicine Market Size Market Share by Application (2019-2024) Table 13. Global Cancer Immuno Personalized Medicine Revenue by Player (2019-2024) & ($ millions) Table 14. Global Cancer Immuno Personalized Medicine Revenue Market Share by Player (2019-2024) Table 15. Cancer Immuno Personalized Medicine Key Players Head office and Products Offered Table 16. Cancer Immuno Personalized Medicine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Cancer Immuno Personalized Medicine Market Size by Region (2019-2024) & ($ millions) Table 20. Global Cancer Immuno Personalized Medicine Market Size Market Share by Region (2019-2024) Table 21. Global Cancer Immuno Personalized Medicine Revenue by Country/Region (2019-2024) & ($ millions) Table 22. Global Cancer Immuno Personalized Medicine Revenue Market Share by Country/Region (2019-2024) Table 23. Americas Cancer Immuno Personalized Medicine Market Size by Country (2019-2024) & ($ millions) Table 24. Americas Cancer Immuno Personalized Medicine Market Size Market Share by Country (2019-2024) Table 25. Americas Cancer Immuno Personalized Medicine Market Size by Type (2019-2024) & ($ millions) Table 26. Americas Cancer Immuno Personalized Medicine Market Size Market Share by Type (2019-2024) Table 27. Americas Cancer Immuno Personalized Medicine Market Size by Application (2019-2024) & ($ millions) Table 28. Americas Cancer Immuno Personalized Medicine Market Size Market Share by Application (2019-2024) Table 29. APAC Cancer Immuno Personalized Medicine Market Size by Region (2019-2024) & ($ millions) Table 30. APAC Cancer Immuno Personalized Medicine Market Size Market Share by Region (2019-2024) Table 31. APAC Cancer Immuno Personalized Medicine Market Size by Type (2019-2024) & ($ millions) Table 32. APAC Cancer Immuno Personalized Medicine Market Size by Application (2019-2024) & ($ millions) Table 33. Europe Cancer Immuno Personalized Medicine Market Size by Country (2019-2024) & ($ millions) Table 34. Europe Cancer Immuno Personalized Medicine Market Size Market Share by Country (2019-2024) Table 35. Europe Cancer Immuno Personalized Medicine Market Size by Type (2019-2024) & ($ millions) Table 36. Europe Cancer Immuno Personalized Medicine Market Size by Application (2019-2024) & ($ millions) Table 37. Middle East & Africa Cancer Immuno Personalized Medicine Market Size by Region (2019-2024) & ($ millions) Table 38. Middle East & Africa Cancer Immuno Personalized Medicine Market Size by Type (2019-2024) & ($ millions) Table 39. Middle East & Africa Cancer Immuno Personalized Medicine Market Size by Application (2019-2024) & ($ millions) Table 40. Key Market Drivers & Growth Opportunities of Cancer Immuno Personalized Medicine Table 41. Key Market Challenges & Risks of Cancer Immuno Personalized Medicine Table 42. Key Industry Trends of Cancer Immuno Personalized Medicine Table 43. Global Cancer Immuno Personalized Medicine Market Size Forecast by Region (2025-2030) & ($ millions) Table 44. Global Cancer Immuno Personalized Medicine Market Size Market Share Forecast by Region (2025-2030) Table 45. Global Cancer Immuno Personalized Medicine Market Size Forecast by Type (2025-2030) & ($ millions) Table 46. Global Cancer Immuno Personalized Medicine Market Size Forecast by Application (2025-2030) & ($ millions) Table 47. AbbVie Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 48. AbbVie Cancer Immuno Personalized Medicine Product Offered Table 49. AbbVie Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 50. AbbVie Main Business Table 51. AbbVie Latest Developments Table 52. Johnson & Johnson Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 53. Johnson & Johnson Cancer Immuno Personalized Medicine Product Offered Table 54. Johnson & Johnson Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 55. Johnson & Johnson Main Business Table 56. Johnson & Johnson Latest Developments Table 57. Novartis Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 58. Novartis Cancer Immuno Personalized Medicine Product Offered Table 59. Novartis Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 60. Novartis Main Business Table 61. Novartis Latest Developments Table 62. Gilead Sciences Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 63. Gilead Sciences Cancer Immuno Personalized Medicine Product Offered Table 64. Gilead Sciences Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 65. Gilead Sciences Main Business Table 66. Gilead Sciences Latest Developments Table 67. Roche Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 68. Roche Cancer Immuno Personalized Medicine Product Offered Table 69. Roche Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 70. Roche Main Business Table 71. Roche Latest Developments Table 72. Bristol-Myers Squibb Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 73. Bristol-Myers Squibb Cancer Immuno Personalized Medicine Product Offered Table 74. Bristol-Myers Squibb Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 75. Bristol-Myers Squibb Main Business Table 76. Bristol-Myers Squibb Latest Developments Table 77. Amgen Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 78. Amgen Cancer Immuno Personalized Medicine Product Offered Table 79. Amgen Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 80. Amgen Main Business Table 81. Amgen Latest Developments Table 82. AstraZeneca Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 83. AstraZeneca Cancer Immuno Personalized Medicine Product Offered Table 84. AstraZeneca Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 85. AstraZeneca Main Business Table 86. AstraZeneca Latest Developments Table 87. Merck & Co Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 88. Merck & Co Cancer Immuno Personalized Medicine Product Offered Table 89. Merck & Co Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 90. Merck & Co Main Business Table 91. Merck & Co Latest Developments Table 92. Takeda Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 93. Takeda Cancer Immuno Personalized Medicine Product Offered Table 94. Takeda Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 95. Takeda Main Business Table 96. Takeda Latest Developments Table 97. Merck KGaA Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 98. Merck KGaA Cancer Immuno Personalized Medicine Product Offered Table 99. Merck KGaA Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 100. Merck KGaA Main Business Table 101. Merck KGaA Latest Developments Table 102. Seagen Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 103. Seagen Cancer Immuno Personalized Medicine Product Offered Table 104. Seagen Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 105. Seagen Main Business Table 106. Seagen Latest Developments Table 107. Eli Lilly Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 108. Eli Lilly Cancer Immuno Personalized Medicine Product Offered Table 109. Eli Lilly Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 110. Eli Lilly Main Business Table 111. Eli Lilly Latest Developments Table 112. Ono Pharmaceutical Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 113. Ono Pharmaceutical Cancer Immuno Personalized Medicine Product Offered Table 114. Ono Pharmaceutical Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 115. Ono Pharmaceutical Main Business Table 116. Ono Pharmaceutical Latest Developments Table 117. Pfizer Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 118. Pfizer Cancer Immuno Personalized Medicine Product Offered Table 119. Pfizer Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 120. Pfizer Main Business Table 121. Pfizer Latest Developments Table 122. GSK Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 123. GSK Cancer Immuno Personalized Medicine Product Offered Table 124. GSK Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 125. GSK Main Business Table 126. GSK Latest Developments Table 127. Exelixis Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 128. Exelixis Cancer Immuno Personalized Medicine Product Offered Table 129. Exelixis Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 130. Exelixis Main Business Table 131. Exelixis Latest Developments Table 132. Regeneron Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 133. Regeneron Cancer Immuno Personalized Medicine Product Offered Table 134. Regeneron Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 135. Regeneron Main Business Table 136. Regeneron Latest Developments Table 137. Innovent Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 138. Innovent Cancer Immuno Personalized Medicine Product Offered Table 139. Innovent Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 140. Innovent Main Business Table 141. Innovent Latest Developments Table 142. Hengrui Medicine Details, Company Type, Cancer Immuno Personalized Medicine Area Served and Its Competitors Table 143. Hengrui Medicine Cancer Immuno Personalized Medicine Product Offered Table 144. Hengrui Medicine Cancer Immuno Personalized Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 145. Hengrui Medicine Main Business Table 146. Hengrui Medicine Latest Developments List of Figures Figure 1. Cancer Immuno Personalized Medicine Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Cancer Immuno Personalized Medicine Market Size Growth Rate 2019-2030 ($ millions) Figure 6. Cancer Immuno Personalized Medicine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Cancer Immuno Personalized Medicine Sales Market Share by Country/Region (2023) Figure 8. Cancer Immuno Personalized Medicine Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Cancer Immuno Personalized Medicine Market Size Market Share by Type in 2023 Figure 10. Cancer Immuno Personalized Medicine in Lung Cancer Figure 11. Global Cancer Immuno Personalized Medicine Market: Lung Cancer (2019-2024) & ($ millions) Figure 12. Cancer Immuno Personalized Medicine in Breast Cancer Figure 13. Global Cancer Immuno Personalized Medicine Market: Breast Cancer (2019-2024) & ($ millions) Figure 14. Cancer Immuno Personalized Medicine in Prostate Cancer Figure 15. Global Cancer Immuno Personalized Medicine Market: Prostate Cancer (2019-2024) & ($ millions) Figure 16. Cancer Immuno Personalized Medicine in Blood-related Cancer Figure 17. Global Cancer Immuno Personalized Medicine Market: Blood-related Cancer (2019-2024) & ($ millions) Figure 18. Cancer Immuno Personalized Medicine in Other Figure 19. Global Cancer Immuno Personalized Medicine Market: Other (2019-2024) & ($ millions) Figure 20. Global Cancer Immuno Personalized Medicine Market Size Market Share by Application in 2023 Figure 21. Global Cancer Immuno Personalized Medicine Revenue Market Share by Player in 2023 Figure 22. Global Cancer Immuno Personalized Medicine Market Size Market Share by Region (2019-2024) Figure 23. Americas Cancer Immuno Personalized Medicine Market Size 2019-2024 ($ millions) Figure 24. APAC Cancer Immuno Personalized Medicine Market Size 2019-2024 ($ millions) Figure 25. Europe Cancer Immuno Personalized Medicine Market Size 2019-2024 ($ millions) Figure 26. Middle East & Africa Cancer Immuno Personalized Medicine Market Size 2019-2024 ($ millions) Figure 27. Americas Cancer Immuno Personalized Medicine Value Market Share by Country in 2023 Figure 28. United States Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 29. Canada Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 30. Mexico Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 31. Brazil Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 32. APAC Cancer Immuno Personalized Medicine Market Size Market Share by Region in 2023 Figure 33. APAC Cancer Immuno Personalized Medicine Market Size Market Share by Type (2019-2024) Figure 34. APAC Cancer Immuno Personalized Medicine Market Size Market Share by Application (2019-2024) Figure 35. China Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 36. Japan Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 37. South Korea Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 38. Southeast Asia Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 39. India Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 40. Australia Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 41. Europe Cancer Immuno Personalized Medicine Market Size Market Share by Country in 2023 Figure 42. Europe Cancer Immuno Personalized Medicine Market Size Market Share by Type (2019-2024) Figure 43. Europe Cancer Immuno Personalized Medicine Market Size Market Share by Application (2019-2024) Figure 44. Germany Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 45. France Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 46. UK Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 47. Italy Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 48. Russia Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 49. Middle East & Africa Cancer Immuno Personalized Medicine Market Size Market Share by Region (2019-2024) Figure 50. Middle East & Africa Cancer Immuno Personalized Medicine Market Size Market Share by Type (2019-2024) Figure 51. Middle East & Africa Cancer Immuno Personalized Medicine Market Size Market Share by Application (2019-2024) Figure 52. Egypt Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 53. South Africa Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 54. Israel Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 55. Turkey Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 56. GCC Countries Cancer Immuno Personalized Medicine Market Size Growth 2019-2024 ($ millions) Figure 57. Americas Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 58. APAC Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 59. Europe Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 60. Middle East & Africa Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 61. United States Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 62. Canada Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 63. Mexico Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 64. Brazil Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 65. China Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 66. Japan Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 67. Korea Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 68. Southeast Asia Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 69. India Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 70. Australia Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 71. Germany Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 72. France Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 73. UK Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 74. Italy Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 75. Russia Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 76. Egypt Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 77. South Africa Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 78. Israel Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 79. Turkey Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 80. GCC Countries Cancer Immuno Personalized Medicine Market Size 2025-2030 ($ millions) Figure 81. Global Cancer Immuno Personalized Medicine Market Size Market Share Forecast by Type (2025-2030) Figure 82. Global Cancer Immuno Personalized Medicine Market Size Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie|||Johnson & Johnson|||Novartis|||Gilead Sciences|||Roche|||Bristol-Myers Squibb|||Amgen|||AstraZeneca|||Merck & Co|||Takeda|||Merck KGaA|||Seagen|||Eli Lilly|||Ono Pharmaceutical|||Pfizer|||GSK|||Exelixis|||Regeneron|||Innovent|||Hengrui Medicine